Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/EBIT(x) 2.69-15.16-30.89-26.57

What is the latest EV/EBIT ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EV/EBIT ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 2.69 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar20262.69
Mar2025-15.16
Mar2024-30.89
Mar2023-26.57

How is EV/EBIT of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EV/EBIT % Change
Mar2026 2.69
Positive
Mar2025 -15.16
Negative
Mar2024 -30.89
Negative
Mar2023 -26.57 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EV/EBIT ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,678.2 Cr 6.5% 5.5% 37% Stock Analytics
PRIME FOCUS ₹26,186.3 Cr 0.5% 9.3% 90.6% Stock Analytics
SAGILITY ₹21,520.1 Cr 2.6% 6.4% 0.3% Stock Analytics
SYNGENE INTERNATIONAL ₹15,404.0 Cr 0.4% -4.2% -42% Stock Analytics
INDEGENE ₹14,413.4 Cr 1.2% 5.6% 1.2% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹14,356.3 Cr 5.3% -2.4% -15.3% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

6.5%

5.5%

37%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses